RMD - ResMed Inc.

NYSE - NYSE Delayed Price. Currency in USD
119.63
+1.13 (+0.95%)
At close: 4:01PM EDT
Stock chart is not supported by your current browser
Previous Close118.50
Open119.50
Bid119.41 x 800
Ask119.42 x 1200
Day's Range118.98 - 119.81
52 Week Range90.64 - 120.00
Volume441,738
Avg. Volume661,376
Market Cap17.154B
Beta (3Y Monthly)0.33
PE Ratio (TTM)38.73
EPS (TTM)3.09
Earnings DateJul 31, 2019 - Aug 5, 2019
Forward Dividend & Yield1.48 (1.25%)
Ex-Dividend Date2019-05-08
1y Target Est109.29
Trade prices are not sourced from all markets
  • Here’s What Hedge Funds Think About ResMed Inc. (RMD)
    Insider Monkey19 hours ago

    Here’s What Hedge Funds Think About ResMed Inc. (RMD)

    Is ResMed Inc. (NYSE:RMD) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting for known risk attributes. […]

  • TheStreet.com2 days ago

    ResMed Could Rally Another 25% From Here

    During Friday night's Lightning Round of Mad Money, Jim Cramer said this about ResMed Inc. In the daily bar chart of RMD, below, we can see a wide-swinging sideways market for this stock. The daily On-Balance-Volume (OBV) line has been steady from March, and is close to making a new high for the move up.

  • Why We Like ResMed Inc.’s (NYSE:RMD) 17% Return On Capital Employed
    Simply Wall St.5 days ago

    Why We Like ResMed Inc.’s (NYSE:RMD) 17% Return On Capital Employed

    Today we are going to look at ResMed Inc. (NYSE:RMD) to see whether it might be an attractive investment prospect. In...

  • Business Wire9 days ago

    New Analysis Shows Sleep Apnea More Common in Americas than Previously Thought

    ResMed (RMD) (RMD.AX) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented at the annual SLEEP meeting hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research Society.

  • Markit9 days ago

    See what the IHS Markit Score report has to say about ResMed Inc.

    ResMed Inc NYSE:RMDView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for RMD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding RMD totaled $6.23 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • ResMed (RMD) Up 7.2% Since Last Earnings Report: Can It Continue?
    Zacks18 days ago

    ResMed (RMD) Up 7.2% Since Last Earnings Report: Can It Continue?

    ResMed (RMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Does ResMed Inc.'s (NYSE:RMD) Past Performance Indicate A Stronger Future?
    Simply Wall St.20 days ago

    Does ResMed Inc.'s (NYSE:RMD) Past Performance Indicate A Stronger Future?

    Measuring ResMed Inc.'s (NYSE:RMD) track record of past performance is an insightful exercise for investors. It...

  • Business Wire20 days ago

    ResMed Appoints New South Asia General Manager to Help Drive Increased Awareness and Treatment of Sleep Apnea, Other Respiratory Diseases

    ResMed, a world leader in connected health solutions for sleep apnea, lung disease, and other chronic diseases, today announced the appointment of Shubhi Khurana as general manager for India and South Asia.

  • Business Wire22 days ago

    ResMed Announces Participation in the 40th Annual Goldman Sachs Global Healthcare Conference

    ResMed today announced that Rob Douglas, president and chief operating officer, will participate in a fireside chat discussion at the 40th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019, beginning at approximately 10:00 a.m.

  • Business Wire27 days ago

    ResMed Announces Participation in the 39th Annual William Blair Growth Stock Conference

    ResMed today announced that Mick Farrell, chief executive officer, will present at the 39th Annual William Blair Growth Stock Conference on Thursday, June 6, 2019, beginning at approximately 8:40 a.m.

  • ResMed Study Shows Remote Monitoring Benefits on CPAP Use
    Zacks28 days ago

    ResMed Study Shows Remote Monitoring Benefits on CPAP Use

    Results of this study mark a remarkable feat for ResMed's (RMD) medical innovation aimed at treating people suffering from sleep apnea.

  • Business Wire29 days ago

    ResMed Study Finds CPAP Adherence Improved by Remote Monitoring, Self-Monitoring across 3 Countries

    .@ResMed study finds #CPAP adherence improved by remote monitoring, self-monitoring across 3 countries

  • Business Wirelast month

    Age, Gender, Disease Severity Impact Adherence to Long-Term PAP Therapy More Than Previously Thought

    Age, gender, and disease severity all impact long-term #CPAP adherence more than previously thought, according to a million-patient study shown at #ATS2019 #sleepapnea

  • Business Wirelast month

    ResMed Elects Jan De Witte to Its Board of Directors

    ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital SaaS solutions, today announced it has elected experienced business executive Jan De Witte to its board of directors. Mr. De Witte was appointed during ResMed’s regularly scheduled board meeting on May 16, 2019, to fill a newly created directorship, effective immediately.

  • Here's Why You Should Hold on to ResMed (RMD) Stock for Now
    Zackslast month

    Here's Why You Should Hold on to ResMed (RMD) Stock for Now

    ResMed (RMD) continues to see strong sales from SaaS business as well as new mask products and devices.

  • What does ResMed Inc.'s (NYSE:RMD) Balance Sheet Tell Us About Its Future?
    Simply Wall St.last month

    What does ResMed Inc.'s (NYSE:RMD) Balance Sheet Tell Us About Its Future?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...

  • Business Wirelast month

    Brightree Announces Access to CommonWell Health Alliance Network for Home Health and Hospice Customers

    Brightree® today announced plans for its Home Health and Hospice customers to access more than 50,000 provider locations and health systems nationwide via the CommonWell Health Alliance, a nonprofit national trade association of health IT companies, and through CommonWell to Carequality, a national, consensus-built common interoperability framework. This represents an important step forward in bridging the gap between out-of-hospital care providers and the broader care ecosystem, solving for when providers lose visibility into their patients’ care when they enter a post-acute care setting.

  • Thomson Reuters StreetEventslast month

    Edited Transcript of RMD earnings conference call or presentation 2-May-19 8:30pm GMT

    Q3 2019 Resmed Inc Earnings Call

  • ResMed's Revenue Growth Accelerates
    Motley Foollast month

    ResMed's Revenue Growth Accelerates

    The medical-device maker continues to roll out new products and grab market share.

  • Resmed Inc (RMD) Q3 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Resmed Inc (RMD) Q3 2019 Earnings Call Transcript

    RMD earnings call for the period ending March 31, 2019.

  • ResMed's (RMD) Q3 Earnings Beat Estimates, Revenues in Line
    Zacks2 months ago

    ResMed's (RMD) Q3 Earnings Beat Estimates, Revenues in Line

    ResMed (RMD) registers double-digit global revenue growth in Q3 on the back of solid sales from Software-as-a-Service businesses and new mask products plus devices.

  • ResMed (RMD) Q3 Earnings Surpass Estimates
    Zacks2 months ago

    ResMed (RMD) Q3 Earnings Surpass Estimates

    ResMed (RMD) delivered earnings and revenue surprises of 5.95% and -0.19%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press2 months ago

    ResMed: Fiscal 3Q Earnings Snapshot

    The San Diego-based company said it had net income of 73 cents per share. Earnings, adjusted for amortization costs and pretax expenses, came to 89 cents per share. The results exceeded Wall Street expectations. ...

  • Business Wire2 months ago

    ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2019

    SAN DIEGO-- -- Year-over-year revenue grows 12%, gross margin improves 100 basis points, operating profit up 15% MatrixCare contributes positively to revenue, gross margin, and profit ResMed well-positioned for the future Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com ResMed Inc. , a world-leading connected health company, today announced ...